Small Cap Feast

9th April 2024

Dish of the day
No Joiners today
Off the menu
No leavers today


Dish Of The Day:


Admissions: 

Helix Exploration (HEX.L) a helium exploration company with operations in Montana, USA announces admission of its Ordinary Shares to trading on the AIM market of the London Stock Exchange. An Oversubscribed placing with book of demand over £22m to raise gross proceeds of £7.5 million. Placing price per share of 10p. Market capitalisation on Admission of £12.2m. Furthermore, Net proceeds of the fundraise will be used to fund scoping study and appraisal drilling at Ingomar project in Montana.

Delistings: 








Whats baking in the oven?

Potential Initial Public Offerings:


Reverse Takeovers:


Change of Market:

TheWorks (WRKS.L) a multi-channel value retailers of books, arts and crafts, stationery, toys and games, offering customers a differentiated proposition as a value alternative to full price specialist retailers. The Company is listed on the premium segment of the Main market of the London Stock Exchange. The Company has announced its intention to change to the AIM market on the 3 May 2024.


Banquet Buffet

Aura Energy 8.9p £64.9m (AURA.L)
The Company is an Australian-based mineral company with major uranium and polymetallic projects in Africa and Europe. The Company has issued ordinary shares at an exercise price of A$0.052 each arising from an exercise of options. Application will be made for the 6,000,000 New Shares to be admitted to trading on AIM. It is expected that Admission will become effective on or around 16 April 2024.

Crossword Cybersecurity * 4.75p £4.8m (CCS.L)
The cybersecurity solutions company focused on cyber strategy and risk announces its managed cyber-security monitoring service, Nightingale, has had a strong performance in the first quarter of 2024. A key driver for this growth has been international expansion in the Caribbean region, where managed services are being delivered via a local partner, to organisations across the telecommunications, insurance, automotive, and oil and gas sectors. Crossword's partner has been appointed as a preferred cyber security provider for several organisations in the Caribbean, which will be delivered across a series of multi-year contracts. Additionally, this has led to a contract to provide incident response services, following a major cyber-attack on a critical national infrastructure provider, and follow-on cyber security monitoring services.

Diaceutics 104p £88.1m (DXRX.L)
The technology and solutions provider to the pharma and biotech industry announces the appointment of Amie Mc Neice as Vice President of Marketing. Amie previously held senior marketing and business development roles with Almac Group, Fibrus and Kingspan. Amie brings a wealth of marketing leadership experience to the team and will focus on delivering our 3-year marketing vision, brand positioning, messaging and integration of marketing automation. Amie has significant experience in working with US pharma customers.

Hvivo 28.5p £193.9m (HVO.L)
The contract research organisation and operator in testing infectious and respiratory disease products using human challenge clinical trials announces its audited results for the year ended 31 December 2023. Revenue increased 16% to £56m (2022: £48.5m), EBITDA increased 44% to £13m (2022: £9.1m) and Cash and cash equivalents of £37m (2022: £28.4m). 90% of 2024 revenue guidance already contracted with good visibility into 2025.

Loungers 213p £221m (LGRS.L)
The operator of all day café/bar/restaurants across the UK under the Lounge, Cosy Club and Brightside brands announces that Justin Carter is being promoted from his current role of MD of the Lounge brand to the newly created position of Group MD.

Microlise Group 166p £192.5m (SAAS.L)
The provider of transport management software to fleet operators announces its audited results for the twelve months ended 31 December 2023. Revenue increased 12% to £71.7m (FY 2022: £63.2m), Adjusted EBITDA increased 15% to £9.4m (FY 2022: £8.2m) and Adjusted profit before tax increased 17% to £5.6m (FY 2022: £4.8m). Furthermore, Cash and cash equivalents increased 1% to £16.8m (FY 2022: £16.7m). Recent acquisitions of Transportation Management System (TMS) providers, Enterprise Software Systems and Vita Software, as well as vulnerable road user app supplier K-Safe are trading in-line with our expectations.

Oracle Power 0.0235p £1.1m (ORCP.L)
The project developer announces that it has secured an exclusive option to acquire 100% of the Blue Rock Valley Copper and Silver Project, located in the Ashburton Basin in the northwest region of Western Australia. Assays from historical drilling and rock chip sampling suggest the presence of high-grade copper and silver mineralisation, as well as the potential for uranium.

Silver Bullet Data Services 105p £18.3m (SBDS.L)
A provider of AI driven digital transformation services and products announces the following changes to the Board, effective immediately. Darren Poynton will be stepping down as Group CFO and Company secretary. Darren has been an integral part of the business for the past five years, playing a crucial role in driving business growth. Under his financial leadership, Silverbullet successfully navigated an IPO in June 2021 and maintained a trajectory of strong financial performance.

Surgical Innovations 0.5p £4.7m (SUN.L)
The designer, manufacturer and distributor of innovative technology for minimally invasive surgery announces that further to the 19 December 2023 announcement regarding Charmaine Day's intention to step down from her role as Chief Financial Officer, the Company confirms that Charmaine has now left the Group. Michael Roper, an interim financial consultant, has been supporting the business since February 2024 and is now overseeing the finance function.

Venture Life 37p £46.8m (VLG.L)
The Company in developing, manufacturing and commercialising products for the international self-care market announces its audited results for the year ended 31 December 2023. Revenue increased 16.9% to £51.4m (2022: £44.0m), Adjusted EBITDA increased 28.9% to £11.6m (2022: £9.0m) and Adjusted profit before tax increased to £7.3m (2022: £5.6m). Furthermore, Free cash flow increased 71% to £4.8m (2022: 2.8m). Going into 2024, we are committed to a trajectory of continuous improvement in both revenue and profitability.

9 April 2024
*A corporate client of Hybridan LLP or retained by Hybridan LLP for certain services
** Arranged by most recent first
*** Alphabetically arranged

STAY INFORMED

Our daily digest of news from UK listed Small and Mid caps straight to your Inbox.

Disclaimer

This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to any such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific person or entity and is not a personal recommendation to any such person or entity. Recipients should reach an individual investment decision, based upon their respective financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.

The information contained in this document is based on materials and sources that are believed to be reliable; however, such information has not been independently verified and therefore it is not possible to confirm such information as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information contained in this document, nor should it be relied upon as such.

The content of this document includes market commentary and other information which we have prepared in relation to the company referred to in this document, which is our broking client. The provision of this document to you constitutes a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of Regulation 600/2014/EU (MIFID II Regulation).

Any and all opinions expressed are current as of the date appearing on this face of this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.

This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, constitutes non-independent research (as such term is defined in the Financial Conduct Authority’s Conduct of Business Sourcebook to reflect the requirements of the MIFID II Regulation and Directive 2014/65/EU (known as MIFID II)). The individuals who prepared this document may be interested in shares in the company concerned and/or other companies within its sector, may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.

In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority’s Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as relevant persons). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority’s Conduct of Business Sourcebook.

Neither this document, nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.

Where possible this document is made available to all relevant recipients at the same time. Dissemination of research by Hybridan LLP is monitored to ensure that it is only provided to relevant persons. Research prepared by Hybridan LLP is not intended to be received and/or used by any person who is a retail client.

Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.

This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.

MIFID II status of Hybridan LLP research
The cost of production of our corporate research is met by retainers from our corporate broking clients. In addition, from time to time we issue further communications as market commentary (such as our daily newsletter, Small Cap Breakfast), which we consider to constitute a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of the MIFID II Regulation.

Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.

If you would like to unsubscribe, please email enquiries@hybridan.com with “unsubscribe me”.

© Copyright 2024 - Hybridan | Website by Boxed Up Media
First Visit
bookcrossmenu linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram